ClinicalTrials HQ

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Active, not recruiting · NCT06121401 · Registry updated 2026-06-25
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive PatientsAdnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorderActive, not recruitingPhase 42026-06-25NCT06121401

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AstraZeneca806
Mario Negri Institute for Pharmacological Research51

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
A.O. Ordine MaurizianoTorinoItaly1
A.O.U. Citta della Salute e della ScienzaTorinoItaly2
AOU ParmaParmaItaly2
Arcispedale Santa Maria NuovaReggio EmiliaItaly4
Azienda Socio Sanitaria Territoriale (ASST) LarianaSan Fermo della BattagliaItaly1
Istituto Europeo di OncologiaMilanItaly31
Istituto Nazionale dei TumoriMilanItaly9
Istituto Oncologico Veneto IRCCSPadovaItaly29
Ospedale ManzoniLeccoItaly1
Ospedale San LucaLuccaItaly3
Ospedale Santa ChiaraPisaItaly2
Ospedale Umberto IRomaItaly1
Policlinico CareggiFlorenceItaly1
Spedali CiviliBresciaItaly7